Skip to content
Screener

Boston Scientific BSX MedSurg — Cost of products sold

Similar metrics at other companies

Cardinal Health logo
CAHCost of product sold — Cost of products sold
$2.61B-1.1%
SPX Technologies logo
SPXCCost of products sold — Cost of products sold
$88.2M+1.6%
Enerpac Tool Group logo
EPACProducts — Cost of products sold
$56.91M+6.9%
FDP
FDPOther fresh produce — Cost of products sold
$580.63M-1.7%
DMC Global Inc. logo
BOOMArcadia Products — Cost of products sold
$48.76M+6.6%
MML
MMLPSpecialty products — Cost of products sold
$73.91M+41.4%

Other financials

Income statement

See full
Revenue$5.4B+7.5%
Gross profit$3.8B+12.4%
Operating income$1.2B+43.8%
Net income$907.0M+14.1%
EPS (diluted)$0.61+15.1%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$69.19B-54.6%
P/E18.9×-42.3×
P/S3.3×-5.0×

Profitability

See full
Gross margin69.9%+1.7pp
Operating margin19.8%+2.8pp
Net margin17.5%+4.0pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept bsx:CostOfGoodsAndServicesSoldAdjusted.

The source filing: Boston Scientific’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 6:25 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885725-26-000033
(in millions, except percentages)Med Surg% of Net SalesCardiovascular% of Net SalesTotal
Impact of foreign currency fluctuations1
Total net sales$5,203
Segment expenses:
Cost of products sold47828.1%1,06730.5%
Selling, general and administrative expenses55732.8%95927.4%
Research and development expenses1277.5%3439.8%
Other segment items(1)50.3%70.2%
Segment operating income(2)53331.3%1,12532.1%1,658

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Boston Scientific's medsurg — cost of products sold?
Boston Scientific (BSX) reported medsurg — cost of products sold of $478M in Q1 2026.
How has Boston Scientific's medsurg — cost of products sold changed year-over-year?
Boston Scientific's medsurg — cost of products sold increased by 9.9% year-over-year, from $435M to $478M.
What is the long-term trend for Boston Scientific's medsurg — cost of products sold?
Over 3 years (2022 to 2025), Boston Scientific's medsurg — cost of products sold has grown at a 11.0% compound annual growth rate (CAGR), from $1.4B to $1.92B.
What does medsurg — cost of products sold mean?
The direct costs associated with manufacturing and delivering the products sold by the MedSurg segment. This includes raw materials, direct labor, and manufacturing overheads required to produce the medical devices.

Ask your AI about Boston Scientific's medsurg — cost of products sold.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude